• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Office of Research Regulatory Affairs
  • UAMS Health
  • Jobs
  • Giving
  • Regulatory Affairs
    • ClinicalTrials.gov Registration
    • Good Tissue Practice
    • ORRA Monitoring Unit
      • Study Monitoring
      • Study Management Tools
        • Adverse Event Log (Device)
        • Adverse Event Log (Drug)
        • Compensation Log
        • Concomitant Medication Log
        • Delegation of Authority Log
        • Deviation Log
        • Device Accountability Log
        • Device Accountability Log (Use)
        • Eligibility Checklist
        • IND – IDE Monitoring Plan
        • Informed Consent Process Note
        • Regulatory Binder Contents
        • Role of the Medical Monitor
        • Screening-Enrollment Log
        • SIV Agenda
        • Source Data Agreement
        • Specimen Tracking Log
    • ORRA Regulatory Unit
      • Investigational Device Exemption Submission
      • Investigational New Drug Submission
  • Resources For Investigators
    • Research Resources
    • Useful Links
  • Research Policies
  • Contact
  • Staff Listing
  1. University of Arkansas for Medical Sciences
  2. Research and Innovation
  3. Office of Research Regulatory Affairs
  4. Regulatory Affairs
  5. ORRA Monitoring Unit
  6. Study Management Tools
  7. Role of the Medical Monitor

Role of the Medical Monitor

The Medical Monitor should be a person not involved in the study so that they can render an independent, non-biased decision regarding protocol changes, evaluation of adverse events, and enrollment of subjects not meeting protocol requirements. Also, they must not have a conflict of interest. The Medical Monitor should be a licensed MD/DO, but not necessarily one involved in the specific disease state being treated under the protocol for which they are the Medical Monitor.


Duties include:

• Ongoing monitoring and evaluation of reports of SAEs related to the study submitted by the study site in real time to ensure good clinical practice and to identify safety concerns quickly.

• Suggest protocol modifications to prevent the occurrence of particular AEs, e.g., modifying the protocol to require frequent measurement of laboratory values predictive of the event or to improve expeditious identification of SAEs.

• May serve as a resource to the clinical investigators and the Sponsor for advice about management of SAEs, but may not be involved in other aspects of the trial.

• Evaluation of all SAEs from each site active under the protocol for which they are the Medical Monitor.

• Evaluating whether the potential deviation from granting an inclusion/exclusion waiver would be justifiable by determining if the deviation would be considered ‘safe’ for the subject [ONLY when permitted by protocol].

University of Arkansas for Medical Sciences LogoUniversity of Arkansas for Medical SciencesUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Legal Notices

© 2026 University of Arkansas for Medical Sciences